Study to Test the Usefulness of Magnetoencephalography (MEG) Imaging of Cognition in Children and Adolescents
NCT ID: NCT00924300
Last Updated: 2023-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2009-07-15
2017-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Magnetic Resonance Imaging (fMRI) Study of Memory in Children
NCT00242905
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
NCT00001246
Neural Injury in Adolescents With Concussion
NCT03011983
Pediatric Neuroimaging
NCT06912724
Brain Activity by Magnetoencephalography for Children
NCT04629482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients
children and/or adolescents with psychiatric disorder
No interventions assigned to this group
controls
typically-developing children/adolescents
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatient at study entry.
* Age 4-18 (inclusive).
* Male or female.
* Have ability to sit still for 5 minutes or longer.
* Have ability to comply with basic instructions.
* Provide written informed assent if willing and able, per local IRB requirements before any study specific procedures are performed.
* Parent or legal guardian provide written informed consent before any study specific procedures are performed.
Exclusion Criteria
* Metal braces on teeth (i.e. Invisalign braces and cavity fillings are permitted).
* Has major medical condition, including cancer or hepatitis.
* Has confounding multiple psychiatric and/or developmental diagnoses, as judged by the principal or co-investigator.
* Known history or diagnosis of alcohol or substance abuse/dependence.
* Unable or unwilling to comply with the protocol.
* Anyone deemed as not appropriate for study participation, as deemed by the principal investigator.
4 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nebraska
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tony W Wilson, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Nebraska
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Nebraska Medical Center
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0217-09-FB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.